Ibogaine Cost and Taxes: HSA, FSA, and Deductions
Ibogaine cost is a large out-of-pocket expense, so here is how tax deductions, HSAs, and FSAs actually treat it and what to document.
Read the article →Expert-reviewed resources to help you make informed decisions about ibogaine therapy
Detailed information on medical screening, dosing protocols, and clinical procedures used in professional treatment centers.
Learn MoreComprehensive safety protocols, contraindications, and medical screening requirements to ensure patient safety.
Read GuidelinesAccess to peer-reviewed studies, clinical trial data, and research on efficacy for various conditions.
View ResearchResources for patients and families, including preparation guides, aftercare information, and support networks.
Get SupportObjective criteria for evaluating treatment centers, including safety protocols, medical staff, and facility standards.
Compare ClinicsAnswers to common questions about ibogaine treatment, costs, preparation, and what to expect during therapy.
Browse FAQsOur comprehensive resource is referenced by medical professionals, treatment centers, and patients seeking evidence-based information about ibogaine therapy.
Ibogaine represents one of the most promising developments in addiction medicine. The clinical evidence for its efficacy in interrupting opioid dependence continues to grow, supported by both preclinical research and observational studies.
Published Clinical Research, 2024–2026Ibogaine cost is a large out-of-pocket expense, so here is how tax deductions, HSAs, and FSAs actually treat it and what to document.
Read the article →Ibogaine safety depends on more than an ECG: potassium, magnesium and hydration status shape cardiac risk before, during and after a treatment session.
Read the article →Ibogaine research has produced real signals and real limits, and the open questions tell you how much weight the current evidence can carry.
Read the article →Ibogaine therapy is often described in absolute terms, so this guide sets out plainly what the evidence does not support and what it cannot replace.
Read the article →Ibogaine success rate evidence varies wildly between sources, and five specific questions will tell you whether a number is worth anything.
Read the article →An ibogaine and methadone taper raises cardiac questions that screening must answer first, because both drugs can affect the heart's QT interval.
Read the article →